Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ying Li has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Chenjiao Yao

    Correspondence to: Prof. Chenjiao Yao, Department of General Medicine, The 3rd Xiangya Hospital, Central South University, 138 Tongzipo road, Yuelu District, Changsha 410013, Hunan, China

    1 shared publication
  • Chunxiang Qin

    Health Management Medicine Center and nursing department, the Third Xiangya Hospital of Central South University, Changsha 410013, China

    1 shared publication
  • Daniel Jones

    Department of Pathology, The Ohio State University, Columbus, OH

    1 shared publication
  • Gui Xiao

    School of Xiangya Nursing, Central South University, Changsha, Hunan Province 410000, People's Republic of China

    1 shared publication
  • Guojuan Zhang

    The James Comprehensive Cancer Center and Solove Research Institute, The Ohio State University, Columbus, OH 43210, USA

    1 shared publication
  • Hu Wang

    School of Xiangya Nursing, Central South University, Changsha, Hunan Province 410000, People's Republic of China

    1 shared publication

Latest Publications

  • Experience of postpartum depression among Chinese women: A meta-synthesis of qualitative research

    by Gui Xiao, Jiaji Hu, Hu Wang, Qiyu Li, Sha Peng, Chunxiang Qin, Ying Li


  • Open Access

    Detection of Pathogenic Isoforms of IKZF1 in Leukemic Cell Lines and Acute Lymphoblastic Leukemia Samples: Identification of a Novel Truncated IKZF1 Transcript in SUP-B15

    by Weiqiang Zhao, Ying Li, Chenjiao Yao, Guojuan Zhang, Kevin Y. Zhao, Wei Chen, Peng Ru, Xiaokang Pan, Huolin Tu, Daniel Jones

    Leukemia-associated alternative splicing of IKZF1 can result in proteins with loss of one to four copies of its N-terminal zinc finger domains (N-ZnF). The best characterized pathogenic splice isoforms, Ik-6 and Ik-8, have been commonly found in BCR-ABL1+ acute lymphoblastic leukemia (ALL) and a subset of BCR-ABL1-like ALL. Infantile and childhood ALL that express these pathogenic IKZF1 isoforms have shown inferior clinical outcomes and can be resistant to tyrosine kinase inhibitors. Using ALL cell lines, we designed and validated a method to detect abnormal IKZF1 transcripts. In the SUP-B15 leukemia cell line, we noted novel IKZF1 transcripts that include both an Ik-6 splice and a transcript with a 14 base pair insertion at the C-terminus. There was also increased IKZF2 protein in SUP-B15 as compared to other ALL lines. Expression of Ik-6 could be suppressed by treatment with the pro-apoptotic type II histone deacetylase inhibitor givinostat. In 17 adult ALL samples, we noted the Ik-6 isoforms in 6 of 15 BCR-ABL1−, and 1 of 2 BCR-ABL1+ cases, with Ik-8 also expressed in one case. Cases with Ik-6 expression showed inferior survival as well as older age at presentation, lower expression of CD10 and more commonly a diploid karyotype.


  • Release of copper and indomethacin from intrauterine devices immersed in simulated uterine fluid

    by Xiaowen Zhou, Ying Li, Xiaoqun Jiang, Lu Qiu, Jianping Liu

    Objectives To study the release of cupric ions and indomethacin from copper-bearing intrauterine devices (Cu-IUDs) and to assess the influence of their surface area of copper and the pH of the test medium on the release of cupric ions. Methods Cu-IUDs were incubated in simulated uterine fluid (SUF). The in vitro release of cupric ions and indomethacin was determined by means of a flame atomic absorption spectrometer and a UV 752 spectrophotometer, respectively, over a period of 220 days. The effect of indomethacin on the pH of the SUF was monitored during the cupric ions release study. Results The Cu-IUDs released cupric ions in vitro according to a biphasic pattern. After an initial burst release, the rate slowed down and then became steady. The release of indomethacin from two medicated Cu-IUDs was biphasic and, in both cases, in accordance with the in vitro dissolution model of the drug. The surface area of copper of Cu-IUDs and the pH change induced by indomethacin incorporated in their frame affected the release rate of copper (p < 0.05). Conclusion The surface area of the copper and the pH of the test medium modulate the in vitro release of cupric ions from Cu-IUDs.